Supplementary
hCOL1A1 F GTGCTAAAGGTGCCAATGGT hCOL1A1 R ACCAGGTTCACCGCTGTTAC hHAS1 F TCGGAGATTCGGTGGACTAC hHAS1 R GTCCAACCTTGTGTCCGAGT hHAS2 F ACCGGGGTAAAATTTGGAAC hHAS2 R TAAGGCAGCTGGCAAAAGAT hHAS3 F TTTGCCATTGCTACCATCAA hHAS3 R AGGCCAATGAAGTTCACCAC hB-ACTIN F CGAGCACAGAGCCTCGCCTTTGCC hB-ACTIN R TGTCGACGACGAGCGCGGCGATAT hFN1 F GATGCTCCCACTAACCTCCA hFN1 R CGGTCAGTCGGTATCCTGTT hPOSTN F TTCTGACGCCTCAAAACTGA hPOSTN R TGCTCTCCAAACCTCTACGG hVIM F CGAAAACACCCTGCAATCTT hVIM R ATTCCACTTTGCGTTCAAGG hCOL3 F TAGGTCCATCTGGTCCTGCT hCOL3 R CGAAGCCTCTGTGTCCTTTC hCOL4 F CTCTACGTGCAAGGCAATGA hCOL4 R AGAACAGGAAGGGCATTGTG hLOX F CAGAGGAGAGTGGCTGAAGG hLOX R CCAGGACTCAATCCCTGTGT hTGF-Β1 F GTACCTGAACCCGTGTTGCT hTGF-Β1 R CACGTGCTGCTCCACTTTTA
SUPPLEMENTARY MATERIALS AND METHODS

Pirfenidone normalizes the tumor microenvironment to improve chemotherapy Fluorescent immunohistochemistry and vessel perfusion histology
MCF10CA1a and 4T1 breast tumors were excised from mice, fixed and embedded in optimal cutting temperature compound (OCT). Transverse 40 μm-thick tumor sections were produced using the Tissue-Tek Cryo3 (SAKURA) and immunostained with antibodies against collagen I (ab4710, Abcam 1:100 dilution), CD31 (MEC13.3, BD Biosciences, 1:100 dilution) hyaluronan (ab53842, Abcam 1:100 dilution), fibronectin (Hybridoma, 1:50 dilution) and a-smooth muscle actin (ab5694, Abcam, 1:100) counterstained with 4′,6-diamidino-2-phenylindole (Vector Labs). Antigens were detected using appropriate secondary fluorescent antibodies. Collagen I was detected with Alexa Fluor-647 Goat Anti-Rabbit IgG (H+L) secondary antibody (A-21244, Invitrogen, 1:800 dilution), CD31 with Alexa Fluor-647 Goat Anti-Rat IgG (H+L) secondary antibody (A-21247, Invitrogen, 1:800 dilution), and hyaluronan using Alexa Fluor-647 donkey Anti-sheep IgG (H+L) secondary antibody (A-11015, 1:800 dilution). For blood vessel perfusion analysis, mice were slowly injected with 100 μl of 1 mg/ml biotinylated lycopersicon esculentum (tomato) lectin (Vector Labs) via intracardiac injection 7 minutes prior to euthanization and tumor removal. Upon excision, tumors were fixed in paraformaldehyde, embedded in OCT and frozen. Transverse 40 μm-thick tumor sections were produced and stained with an antibody against the endothelial marker CD31. Streptavidin-conjugated and fluorescently-labelled secondary antibodies against lectin and CD31 were used to detect these antigens, respectively. Lectin staining was detected using the Streptavidin Alexa Fluor 488 conjugate (Molecular probes, S11223, 1:400 dilution) and CD31 signal was detected with Alexa Fluor-647 Goat Anti-Rat IgG (H+L) secondary antibody (Molecular probes, A-21247, 1:800 dilution). Images from anticollagen I, anti-CD31, anti-hyaluronan and anti-biotinstained sections were analysed based on the area fraction of positive staining. To avoid any bias, the analysis was performed automatically using a previously developed inhouse code in MATLAB (MathWorks, Inc., Natick, MA, USA) [1] . Vessel diameter was calculated from the CD31 images. Specifically, the procedure of the identification of the non-collapsed vessels was automated in the MATLAB code. The CD31 staining that forms a loop was considered to be a vessel and the short axis of a cross-section fit to an oval was taken. Five different sections per tumor (from the interior and the periphery) at ×10 magnification were taken and analyzed keeping the analysis settings and thresholds the same for all tumors.
Biodistribution analysis
For the biodistribution study, a dose of 9 mg/kg of doxorubicin was injected via tail vein injection to the animals and 4 hours post injection they were sacrificed.
Six animals per group were tested (n = 6). The tissues were excised from the mice and were stored at −80°C until extraction. For doxorubicin extraction, we used a previously described method with modifications [2] . The tissue samples were homogenized by using a homogenizer in 4 parts (v/w) cell lysis buffer (RIPA buffer). Then in 200 μl of the homogenate were added 50 μl 10% Triton X-100 and 750 μl 0.75N hydrochloric acid (HCl) in isopropanol. The mixture was well-vortexed and let overnight at -20oC for doxorubicin extraction. Samples were again vortexed at RT followed by centrifugation for 30 min at 4°C (14000 rpm). The supernatant was then collected from all samples and fluorescence was measured (Ex.: 470 nm, Em: 590 nm) using the Qubit 3.0 Fluorometer (Life Technologies). A standard curve was established by adding known amounts of doxorubicin to homogenates of non-treated tissue samples prior to extraction.
